Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

20/25/20	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/25/17	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	27.07L 23.29L 21.93L 19.99L 37.39L 26Cr 37.54L 2.6Cr 1Cr 13Cr 1.02Cr 99.44L 42Cr	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	1.28Cr 1.1Cr 1.04Cr 94.7L 1.77Cr 122.06Cr 1.78Cr 12Cr 4.76Cr 62Cr 4.82Cr 4.71Cr 196.99Cr	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

20/25/20	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/25/17	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
11/25/11	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
11/25/11	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
11/25/11	Avinger, Inc. Announces Executive Changes	CI
24/24/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/24/24	US Futures Tread Water Ahead of Holiday Break	MT
24/24/24	Iberdrola Completes Merger with Avangrid	MT
08/24/08	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
08/24/08	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
08/24/08	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
08/24/08	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/24/04	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

21/23/21	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/22/11	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/22/18	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/21/29	Avinger : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

02/25/02	Avinger : Private Placement Form 8 K	PU
08/24/08	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/24/08	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
08/24/08	Avinger: Q3 Earnings Snapshot	AQ
25/24/25	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

AVINGER Share Price Nasdaq

Stocks

Advanced Medical Equipment & Technology

Valuation : AVINGER

Latest news : AVINGER

Analysts' recommendations : AVINGER

Press Releases : AVINGER

Managers and Directors : AVINGER

Medical Imaging Systems

Financials

Company Profile

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	05/08/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-3.27%	-0.70%	-32.62%	-2.46%	1.26TCr
IRAY GROUP	-1.50%	-2.49%	+12.36%	+12.14%	421.67Cr
SONOSCAPE MEDICAL CORP.	-3.45%	+4.76%	-43.56%	-51.84%	128.74Cr
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-2.60%	-4.81%	-42.61%	-42.00%	109.8Cr
IRADIMED CORPORATION	-1.00%	-3.03%	+16.23%	+77.00%	106.85Cr
NINGBO JANSEN SUPERCONDUCTING TECHNOLOGIES CO., LTD.	-3.14%	-7.16%	-	-	100.08Cr
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	-2.61%	-5.20%	-38.22%	-	100.09Cr
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-1.55%	+0.20%	+32.46%	+111.81%	52Cr
CAPSOVISION, INC.	+0.16%	+7.42%	+78.93%	-	32Cr
Average	-2.11%	-0.79%	-2.13%	+17.44%	256.88Cr
Weighted average by Cap.	-2.70%	-1.63%	-19.93%	+2.30%

	2022	2023
Net sales	82.73L 71.19L 67.03L 61.08L 1.14Cr 79Cr 1.15Cr 7.94Cr 3.07Cr 40Cr 3.11Cr 3.04Cr 127.05Cr	76.52L 65.85L 62L 56.49L 1.06Cr 73Cr 1.06Cr 7.35Cr 2.84Cr 37Cr 2.87Cr 2.81Cr 117.52Cr
Net income	-1.76Cr -1.52Cr -1.43Cr -1.3Cr -2.43Cr -167.69Cr -2.44Cr -17Cr -6.54Cr -85Cr -6.62Cr -6.47Cr -270.65Cr	-1.83Cr -1.58Cr -1.48Cr -1.35Cr -2.53Cr -174.33Cr -2.54Cr -18Cr -6.8Cr -89Cr -6.88Cr -6.73Cr -281.35Cr
Net Debt	17.56L 15.11L 14.23L 12.96L 24.26L 17Cr 24.35L 1.69Cr 65.17L 8.51Cr 65.94L 64.5L 27Cr	1.01Cr 87.08L 82L 74.71L 1.4Cr 96Cr 1.4Cr 9.72Cr 3.76Cr 49Cr 3.8Cr 3.72Cr 155.42Cr

End-of-day quote Nasdaq
- ^USD	-